---
title: "NIKOLAOU ANASTASIS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/79d4d16b-38b2-53d5-8bc3-9ceecc565d04
json: https://whiteintel.dev/api/public/dossier/79d4d16b-38b2-53d5-8bc3-9ceecc565d04
identifier: sec:0001954186
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NIKOLAOU ANASTASIS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001954186`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/79d4d16b-38b2-53d5-8bc3-9ceecc565d04  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/79d4d16b-38b2-53d5-8bc3-9ceecc565d04  

## Ownership & control

### Holdings / subsidiaries

- **Acrivon Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/374491c8-21b8-5dc7-9616-741799d55196

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NIKOLAOU ANASTASIS**. Human view: https://whiteintel.dev/entity/79d4d16b-38b2-53d5-8bc3-9ceecc565d04 · Structured JSON: https://whiteintel.dev/api/public/dossier/79d4d16b-38b2-53d5-8bc3-9ceecc565d04._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._